{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:42:30Z","timestamp":1794433350644,"version":"4.9.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1097\/01.jcp.0000088907.24613.3f","type":"journal-article","created":{"date-parts":[[2003,10,17]],"date-time":"2003-10-17T04:08:12Z","timestamp":1066363692000},"page":"505-508","source":"Crossref","is-referenced-by-count":22,"title":["Imipramine and Buspirone in Patients With Panic Disorder Who Are Discontinuing Long-term Benzodiazepine Therapy"],"prefix":"10.1097","volume":"23","author":[{"given":"Moira","family":"Rynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Garc\u00eda-Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Mandos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Rickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199305133281907","article-title":"Use of benzodiazepines in anxiety disorders.","volume":"328","author":"Shader","year":"1993","journal-title":"N Engl J Med"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-199312001-00001","article-title":"Clinical uses of benzodiazepines.","volume":"13","author":"Hollister","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.1097\/00004714-199006001-00013","article-title":"Clinical effects of the 5-HT1Apartial agonists in depression: a composite analysis of buspirone in the treatment of depression.","volume":"10","author":"Robinson","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00432376","article-title":"Entry of diazepam and its major metabolite into cerebrospinal fluid.","volume":"70","author":"Greenblatt","year":"1980","journal-title":"Psychopharmacology"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0378-4347(00)81896-4","article-title":"Analysis of lorazepam and its glucuronide metabolite by electron-capture gas-liquid chromatography: use in pharmacokinetic studies of lorazepam.","volume":"146","author":"Greenblatt","year":"1978","journal-title":"J Chromatogr"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00004714-198312000-00008","article-title":"Automated gas chromatographic determination of plasma alprazolam concentrations.","volume":"3","author":"Greenblatt","year":"1983","journal-title":"J Clin Psychopharmacol"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines, I: effects of abrupt discontinuation.","volume":"47","author":"Rickels","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0447.1973.tb04398.x","article-title":"Length of treatment with anxiolytic sedatives and response to their sudden withdrawal.","volume":"49","author":"Covi","year":"1973","journal-title":"Acta Psychiatr Scand"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness.","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1176\/ajp.128.8.1005","article-title":"Evaluating clinical improvement in anxious outpatients: a comparison of normal and treated neurotic outpatients.","volume":"128","author":"Rickels","year":"1972","journal-title":"Am J Psychiatry"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1176\/appi.ajp.157.12.1973","article-title":"Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.","volume":"157","author":"Rickels","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00004714-199210000-00011","article-title":"Discontinuation of alprazolam after long-term treatment of panic-related disorders.","volume":"12","author":"DuPont","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.","volume":"150","author":"Otto","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/ajp.144.3.303","article-title":"Discontinuation of alprazolam treatment in panic patients.","volume":"144","author":"Fyer","year":"1987","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.jcp.0000088907.24613.3f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:29:36Z","timestamp":1785767376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200310000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000088907.24613.3f","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}